Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06314477

Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial

Effect of CPAP Treatment on Asthma Control in Patients With Severe Uncontrolled Asthma and Obstructive Sleep Apnea: The ASTHMA-SLEEP Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
138 (estimated)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and obstructive sleep apnea (OSA)

Detailed description

Background: The prevalence of obstructive sleep apnea (OSA) is high in patients with severe uncontrolled asthma and can worsen asthma control. Previous observational studies demonstrated that CPAP treatment could improve control in patients with mild-moderate asthma. Nevertheless, there are no studies in patients with severe uncontrolled asthma. Primary objective: To evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and AOS. Methodology: Multicenter, prospective, randomized, controlled clinical trial with parallel groups in subjects with severe uncontrolled asthma who are older than 18 years and without sleepiness (Epworth sleepiness scale score ≤10). All included subjects will undergo conventional polysomnography and those with an apnea-hypopnea index (AHI) ≥15/hour will be randomized in a 1:1 ratio to receive conservative treatment or conservative treatment plus CPAP. Monitoring will be carried out during12 months. Patients will be evaluated at inclusion, at 1 month, 6 and 12 months.

Conditions

Interventions

TypeNameDescription
DEVICECPAP treatmentSubjects allocated to this arm will receive continuous positive airway pressure (CPAP)
OTHERHygienic and dietary adviceSubjects allocated to this arm will receive hygienic and dietary counselling

Timeline

Start date
2023-12-27
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2024-03-18
Last updated
2025-12-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06314477. Inclusion in this directory is not an endorsement.